Showing results (2361-2370 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|March 11, 2022
Phase I Trial of a Third Generation EGFR Mutant-Selective Inhibitor (D-0316) in Patients with Advanced Non-Small Cell Lung CancerHong Jian, Kai Wang, Ying Cheng, et al.The Oncologist|March 11, 2022
Perspectives of Young Women With Gynecologic Cancers on Fertility and Fertility Preservation: A Systematic ReviewVânia Gonçalves, Pedro L Ferreira, Mona Saleh, et al.The Oncologist|March 24, 2022
Phase I Study of Lenvatinib and Capecitabine with External Radiation Therapy in Locally Advanced Rectal AdenocarcinomaRutika Mehta, Jessica Frakes, Jongphil Kim, et al.The Oncologist|March 24, 2022
Prevention of Pemetrexed-Induced Rash Using Low-Dose Corticosteroids: A Phase II StudyTakumi Sakurada, Hiroshi Nokihara, Tadashi Koga, et al.The Oncologist|June 6, 2019
A Systematic Review and Network Meta-Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal CancerMohamad Bassam Sonbol, Raed Benkhadra, Zhen Wang, et al.The Oncologist|October 10, 2018
Phase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid CancerJaydira Del Rivero, Maureen Edgerly, Jean Ward, et al.The Oncologist|October 12, 2019
Identifying Barriers and Facilitators to Breast Cancer Early Detection and Subsequent Treatment Engagement in Kenya: A Qualitative ApproachRobai Gakunga, Asaph Kinyanjui, Zipporah Ali, et al.The Oncologist|August 25, 2018
A Phase I Dose-Escalation Study of Linsitinib (OSI-906), a Small-Molecule Dual Insulin-Like Growth Factor-1 Receptor/Insulin Receptor Kinase Inhibitor, in Combination with Irinotecan in Patients with Advanced CancerS Lindsey Davis, S Gail Eckhardt, Jennifer R Diamond, et al.The Oncologist|May 11, 2019
Metastatic Adrenal Cortical Carcinoma Responding to Octreotide: A Case ReportXiang Wang, Na Zhou, Yu Xiao, et al.The Oncologist|May 11, 2019
A Practical Guide for the Follow-Up of Patients with Advanced Basal Cell Carcinoma During Treatment with Hedgehog Pathway InhibitorsClio Dessinioti, Mikaella Plaka, Efthymia Soura, et al.Pageof 571